Stock Movers: Novo Nordisk's Alzheimer's Pill Fails, Amazon Expands AI, Tesla Jumps on Chip News

Novo Nordisk's Alzheimer's Trial Setback

• 📉 Novo Nordisk shares declined significantly after a pill version of its Ozempic drug failed to slow Alzheimer's progression in a clinical trial.
• 💡 The company had hoped to find a new use case for its blockbuster obesity drug as competition in the GLP-1 market intensifies.
• ⚠️ The failure removes a key hope for a near-term revival for Novo Nordisk, which has faced competition from companies like Eli Lilly.
• 🔬 Novo Nordisk will discontinue the planned one-year extension of the study, indicating a significant risk taken that did not pay off.

Amazon's AI Infrastructure Expansion

• 🚀 Amazon is set to invest up to $50 billion to expand its capacity for providing artificial intelligence and high-performance computing services to US government entities.
• 📊 Amazon Web Services (AWS) currently supports over 11,000 government agencies and plans to add 1.3 gigawatts of additional capacity across data centers for federal agencies.
• 📈 While the stock saw a rise, some of the rally may be attributed to investors returning to big tech after a volatile previous week.

Tesla's AI Chip Progress Boosts Stock

• ⚡ Tesla shares experienced a significant jump, marking their biggest intraday move since September.
• 💬 The surge followed an announcement from Elon Musk on X, indicating progress on the company's AI chip plans.
• 🛠️ Tesla is reportedly close to taping out its A15 chips and beginning work on A16 chips, currently using A14 chips in its vehicles.
• 🚗 This move highlights a trend of auto companies developing their own chips to avoid supply chain issues, as experienced in recent years.